![Thomas Klaue](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Klaue
Vorstandsvorsitzender bei
INJEX Pharma AG
Profil
Thomas Klaue currently works at INJEX Pharma AG, as Chief Executive Officer from 2013 and Siqens GmbH, as Chief Executive Officer from 2022.
Dr. Klaue also formerly worked at MediGene AG, as Chief Financial Officer.
Aktive Positionen von Thomas Klaue
| Unternehmen | Position | Beginn |
|---|---|---|
INJEX Pharma AG
 INJEX Pharma AG Medical SpecialtiesHealth Technology Manufactures needle free injection equipment | Vorstandsvorsitzender | 30.06.2013 |
Siqens GmbH
 Siqens GmbH Electrical ProductsProducer Manufacturing Develops methanol fuel cells for serial production | Vorstandsvorsitzender | 01.07.2022 |
Ehemalige bekannte Positionen von Thomas Klaue
| Unternehmen | Position | Ende |
|---|---|---|
| MEDIGENE AG | Finanzdirektor/CFO | 19.04.2010 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
13
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
MediGene AG
 MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
INJEX Pharma AG
INJEX Pharma AG Medical SpecialtiesHealth Technology Manufactures needle free injection equipment | Health Technology |
Siqens GmbH
Siqens GmbH Electrical ProductsProducer Manufacturing Develops methanol fuel cells for serial production | Producer Manufacturing |
